Patents abound for treating rosacea with alpha agonists

Written by on December 19, 2007 in Oxymetazoline, patents, Sansrosa with 0 Comments

Their has been much talk lately about using alpha adrenoceptor agonists as rosacea treatments because they show vasoconstrictor actions. Some examples are brimonidine, oxymetazoline, naphazoline, and others.

There are quite a few patents out there discussing these, and even testing some of them. Some of these patents have been mentioned before on the site.

Here are links to some of these patents.

  • US20040242588
  • Compounds, formulations, and methods for treating or preventing rosacea

  • US20050020600
  • Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists

  • US20050165079
  • Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists

  • US20050276830
  • Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

  • US20060171974
    Compounds, formulations, and methods for treating or preventing rosacea
Read more about: Oxymetazoline, patents, Sansrosa

About the Author

About the Author: .

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

Leave your comment here

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.